Rare diseases
Investigational molecules
Locations
Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
FranceSafety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
PolandPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
DenmarkPhase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations
BelgiumA Phase II Study of Cadonilimab Plus Lenvatinib Versus Lenvatinib in Advanced Hepatocellular Carcinoma After Atezolizumab/Bevacizumab Progression
FranceA study of SAR448851 with florquinitau (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanyPhase 1/2 Study Evaluating Safety and Activity of GSK5926371 in Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
FinlandEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
CzechiaSafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
FinlandPhase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)
GermanySafety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression
ItalyStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
